Style | Citing Format |
---|---|
MLA | Mirzaei HR, et al.. "Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers." Current Pharmaceutical Design, vol. 22, no. 34, 2016, pp. 5257-5269. |
APA | Mirzaei HR, Sahebkar A, Mohammadi M, Yari R, Salehi H, Jafari MH, Namdar A, Khabazian E, Jaafari MR, Mirzaei H (2016). Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. Current Pharmaceutical Design, 22(34), 5257-5269. |
Chicago | Mirzaei HR, Sahebkar A, Mohammadi M, Yari R, Salehi H, Jafari MH, Namdar A, Khabazian E, Jaafari MR, Mirzaei H. "Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers." Current Pharmaceutical Design 22, no. 34 (2016): 5257-5269. |
Harvard | Mirzaei HR et al. (2016) 'Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers', Current Pharmaceutical Design, 22(34), pp. 5257-5269. |
Vancouver | Mirzaei HR, Sahebkar A, Mohammadi M, Yari R, Salehi H, Jafari MH, et al.. Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. Current Pharmaceutical Design. 2016;22(34):5257-5269. |
BibTex | @article{ author = {Mirzaei HR and Sahebkar A and Mohammadi M and Yari R and Salehi H and Jafari MH and Namdar A and Khabazian E and Jaafari MR and Mirzaei H}, title = {Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers}, journal = {Current Pharmaceutical Design}, volume = {22}, number = {34}, pages = {5257-5269}, year = {2016} } |
RIS | TY - JOUR AU - Mirzaei HR AU - Sahebkar A AU - Mohammadi M AU - Yari R AU - Salehi H AU - Jafari MH AU - Namdar A AU - Khabazian E AU - Jaafari MR AU - Mirzaei H TI - Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers JO - Current Pharmaceutical Design VL - 22 IS - 34 SP - 5257 EP - 5269 PY - 2016 ER - |